Reprint of: Prevention and Treatment of Tobacco Use: JACC Health Promotion Series.

Tobacco use is the leading preventable cause of death worldwide and is a major risk factor for cardiovascular disease (CVD). Both prevention of smoking initiation among youth and smoking cessation among established smokers are key for reducing smoking prevalence and the associated negative health consequences. Proven tobacco cessation treatment includes pharmacotherapy and behavioral support, which are most effective when provided together. First-line medications (varenicline, bupropion, and nicotine replacement) are effective and safe for patients with CVD. Clinicians who care for patients with CVD should give as high a priority to treating tobacco use as to managing other CVD risk factors. Broader tobacco control efforts to raise tobacco taxes, adopt smoke-free laws, conduct mass media campaigns, and restrict tobacco marketing enhance clinicians' actions working with individual smokers.

• Publication year

  2018

• Venue

  Journal of the American College of Cardiology

• Publication date

  2018-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jacc.2018.10.020PMID 30522631
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tobacco Product Use Among Adults — United States, 2019

  2020cited by this paper
• Temporal Trends of Sources of Cigarettes Among US High School Students: 2001–2015

  2019cited by this paper
• Hypnotherapy for smoking cessation.

  2019cited by this paper
• Combined pharmacotherapy and behavioural interventions for smoking cessation

  2019cited by this paper
• Potential Public Health Effects of Reducing Nicotine Levels in Cigarettes in the United States

  2018cited by this paper
• Smoking abstinence 1 year after acute coronary syndrome: follow-up from a randomized controlled trial of varenicline in patients admitted to hospital

  2018cited by this paper
• E-Cigarettes and the Harm-Reduction Continuum.

  2018cited by this paper
• Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports

  2018cited by this paper
• Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial

  2018cited by this paper
• The tobacco atlas.

  2018cited by this paper
• Tobacco-Product Use by Adults and Youths in the United States in 2013 and 2014.

  2018cited by this paper
• Treatment With Bupropion and Varenicline for Smoking Cessation and the Risk of Acute Cardiovascular Events and Injuries: a Swedish Case-Crossover Study

  2018cited by this paper
• Public Health Consequences of e-Cigarette Use

  2018cited by this paper
• Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports

  2018cited by this paper
• Mass media interventions for smoking cessation in adults.

  2017cited by this paper
• Tobacco Use Among Middle and High School Students — United States, 2011–2016

  2017cited by this paper
• Smoking cessation and outcome after ischemic stroke or TIA

  2017cited by this paper
• Individual behavioural counselling for smoking cessation.

  2017cited by this paper
• Cigarette Smoking and Mortality in Adults Aged 70 Years and Older: Results From the NIH-AARP Cohort.

  2017cited by this paper
• Group behaviour therapy programmes for smoking cessation.

  2017cited by this paper
• Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015

  2017cited by this paper
• Use of Prescription Smoking Cessation Medications After Myocardial Infarction Among Older Patients in Community Practice

  2017cited by this paper
• Implementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries: an association study.

  2017cited by this paper
• Reduced nicotine content cigarettes and use of alternative nicotine products: exploratory trial

  2017cited by this paper
• Longitudinal Associations of Local Cigarette Prices and Smoking Bans with Smoking Behavior in the Multi-Ethnic Study of Atherosclerosis

  2017cited by this paper
• Loss of Cardioprotective Effects at the ADAMTS7 Locus as a Result of Gene-Smoking Interactions

  2017cited by this paper
• Cardiovascular and Neuropsychiatric Events after Varenicline Use for Smoking Cessation

  2017cited by this paper
• Tobacco Smoking Is a Medical Problem. We Ought to Treat It Like One.

  2017cited by this paper
• A Nicotine-Focused Framework for Public Health.

  2017cited by this paper
• Tobacco Product Use Among Adults — United States, 2015

  2017cited by this paper
• Reduced nicotine content cigarettes, e-cigarettes and the cigarette end game.

  2017cited by this paper
• Quitting Smoking Among Adults - United States, 2000-2015.

  2017cited by this paper
• Tobacco‐Product Use by Adults and Youths in the United States in 2013 and 2014

  2017cited by this paper
• Accelerated Adoption of Smoke-Free Laws After Ratification of the World Health Organization Framework Convention on Tobacco Control.

  2016cited by this paper
• Awareness and use of electronic cigarettes and heat-not-burn tobacco products in Japan.

  2016cited by this paper
• Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.

  2016cited by this paper
• Nicotine receptor partial agonists for smoking cessation.

  2016cited by this paper
• FCTC followed by accelerated implementation of tobacco advertising bans

  2016cited by this paper
• Varenicline for Smoking Cessation in Hospitalized Patients With Acute Coronary Syndrome

  2016cited by this paper
• Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

  2016cited by this paper
• Mobile phone-based interventions for smoking cessation.

  2016cited by this paper
• Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers

  2016cited by this paper
• Randomized Trial of Reduced-Nicotine Standards for Cigarettes.

  2015cited by this paper
• Current Cigarette Smoking Among Adults — United States, 2016

  2015cited by this paper
• Public Health Implications of Raising the Minimum Age of Legal Access to Tobacco Products

  2015cited by this paper
• Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study

  2015cited by this paper
• Smoking and mortality--beyond established causes.

  2015cited by this paper
• Association of Smoking Status With Angina and Health-Related Quality of Life After Acute Myocardial Infarction

  2015cited by this paper
• Smoking and mortality--beyond established causes.

  2015cited by this paper
• Does reduced smoking if you can’t stop make any difference?

  2015cited by this paper
• Activation of AMPKα2 in adipocytes is essential for nicotine-induced insulin resistance in vivo

  2015cited by this paper
• Association of Smoke-Free Laws With Lower Percentages of New and Current Smokers Among Adolescents and Young Adults: An 11-Year Longitudinal Study.

  2015cited by this paper
• The Contribution of Tobacco Use to High Health Care Utilization and Medical Costs in Peripheral Artery Disease: A State-Based Cohort Analysis.

  2015influential reference
• Tobacco Use Screening and Counseling During Hospital Outpatient Visits Among US Adults, 2005–2010

  2015cited by this paper
• Psychosocial interventions for smoking cessation in patients with coronary heart disease.

  2015cited by this paper
• Relationship of Cigarette Smoking With Inflammation and Subclinical Vascular Disease: The Multi-Ethnic Study of Atherosclerosis

  2015cited by this paper
• Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis.

  2014cited by this paper
• Natural history of attempts to stop smoking.

  2014cited by this paper
• Current Cigarette Smoking Among Adults — United States, 2005–2013

  2014cited by this paper
• The Health consequences of smoking—50 years of progress : a report of the Surgeon General

  2014cited by this paper
• Compensatory Smoking from Gradual and Immediate Reduction in Cigarette Nicotine Content

  2014cited by this paper
• Acupuncture and related interventions for smoking cessation.

  2014cited by this paper
• Effect of smoke-free legislation on perinatal and child health: a systematic review and meta-analysis.

  2014cited by this paper
• The relation between number of smoking friends, and quit intentions, attempts, and success: findings from the International Tobacco Control (ITC) Four Country Survey.

  2014cited by this paper
• Discontinuation of Smokeless Tobacco and Mortality Risk After Myocardial Infarction

  2014cited by this paper
• Antidepressants for smoking cessation.

  2014cited by this paper
• UNIVERSITE DE LAUSANNE-FACULTE DE BIOLOGIE ET DE MEDECINE

  2014cited by this paper
• Cardiovascular Events Associated With Smoking Cessation Pharmacotherapies: A Network Meta-Analysis

  2014cited by this paper
• Effect of smoke-free legislation on perinatal and child health: a systematic review and meta-analysis.

  2014cited by this paper
• Association between clean indoor air laws and voluntary smokefree rules in homes and cars

  2013cited by this paper
• Bupropion for smoking cessation in patients hospitalized with acute myocardial infarction: a randomized, placebo-controlled trial.

  2013cited by this paper
• Physician advice for smoking cessation.

  2013cited by this paper
• 50-year trends in smoking-related mortality in the United States.

  2013cited by this paper
• Cardiovascular Safety of Varenicline: Patient-Level Meta-Analysis of Randomized, Blinded, Placebo-Controlled Trials

  2013cited by this paper
• Telephone counselling for smoking cessation.

  2013cited by this paper
• 21st-century hazards of smoking and benefits of cessation in the United States.

  2013cited by this paper
• Meta-analysis of the association between cigarette smoking and peripheral arterial disease

  2013cited by this paper
• Nicotine receptor partial agonists for smoking cessation

  2012cited by this paper
• Interventions for smoking cessation in hospitalised patients.

  2012cited by this paper
• Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis

  2012cited by this paper
• Cigarette smoking exposure and heart failure risk in older adults: the Health, Aging, and Body Composition Study.

  2012cited by this paper
• Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study

  2012cited by this paper
• Meta‐analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms

  2012cited by this paper
• Nicotine replacement therapy for smoking cessation.

  2012cited by this paper
• The Clinical Effort Against Secondhand Smoke Exposure (CEASE) Intervention: A Decade of Lessons Learned.

  2012cited by this paper
• Epidemiology and Prevention Association Between Smoke-Free Legislation and Hospitalizations for Cardiac, Cerebrovascular, and Respiratory Diseases

  2012cited by this paper
• Association Between Smoke-Free Legislation and Hospitalizations for Cardiac, Cerebrovascular, and Respiratory Diseases: A Meta-Analysis

  2012cited by this paper
• Combined pharmacotherapy and behavioural interventions for smoking cessation

  2012cited by this paper
• Meta-analysis of the association between secondhand smoke exposure and stroke.

  2011cited by this paper
• Cytokines present in smokers' serum interact with smoke components to enhance endothelial dysfunction.

  2011cited by this paper
• Predictors of persistent nicotine dependence among adults in the United States.

  2011cited by this paper
• Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study.

  2011cited by this paper
• Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis

  2011cited by this paper
• Nicotine receptor partial agonists for smoking cessation.

  2011cited by this paper
• Acupuncture and related interventions for smoking cessation.

  2011cited by this paper
• Bupropion for smoking cessation in patients with acute coronary syndrome.

  2011cited by this paper
• How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General

  2010cited by this paper
• Particulate Matter Air Pollution and Cardiovascular Disease: An Update to the Scientific Statement From the American Heart Association

  2010cited by this paper
• Continuous smoking and progression of arterial stiffening: a prospective study.

  2010cited by this paper
• Early Course of Nicotine Dependence in Adolescent Smokers

  2010cited by this paper

• Nicotine replacement therapy as a smoking cessation tool for adolescents: an update

  2025cites this paper
• Relationship between triglyceride glucose-body mass index baselines and variation with future cardiovascular diseases risk in the middle-aged and elderly individuals

  2025cites this paper
• Relationship of Body Mass Index, Aerobic Capacity, and Heart Rate Variability in Perimenopausal and Postmenopausal Women in Surat City: A Correlational Study

  2025cites this paper
• Dermatological Manifestation of SLE Patients, Living in Aseer Region

  2024cites this paper
• Identification of m7G-related hub biomarkers and m7G regulator expression pattern in immune landscape during the progression of osteoarthritis.

  2023cites this paper
• Spectroscopic Characterization, Cyclic Voltammetry, Biological Investigations, MOE, and Gaussian Calculations of VO(II), Cu(II), and Cd(II) Heteroleptic Complexes

  2023cites this paper
• An imaging-based machine learning model outperforms clinical risk scores for prognosis of cirrhotic variceal bleeding

  2023cites this paper
• Cardiac Involvement in Mitochondrial Disorders

  2023cites this paper
• Identification and validation of BCL6 and VEGFA as biomarkers and ageing patterns correlating with immune infiltrates in OA progression

  2023cites this paper
• The complex role of air pollution on the association between greenness and respiratory mortality: Insight from a large cohort, 2009-2020.

  2023cites this paper
• Epigenetic regulation of inflammation: The metabolomics connection.

  2022cites this paper
• Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits

  2022cites this paper
• Short Tryptamine-Based Peptoids as Potential Therapeutics for Microbial Keratitis: Structure-Function Correlation Studies

  2022cites this paper
• Factors associated with smoking habits among undergraduate medical students: a cross-sectional study

  2021cites this paper
• Atherosclerosis inflammation and burden in young adult smokers and vapers measured by PET/MR.

  2021cites this paper
• Preventing and Treating Tobacco Use

  2021cites this paper
• Study of Black Cumin Seed Oil (BCSO) (Nigella sativa L.) as an Immunomodulator in The Healthy Active Smoker Volunteer

  2021cites this paper
• Diretrizes da Sociedade Brasileira de Cardiologia sobre Angina Instável e Infarto Agudo do Miocárdio sem Supradesnível do Segmento ST – 2021

  2021cites this paper
• Association of smoking and right ventricular function in middle age: CARDIA study

  2020cites this paper
• Dietary Rehabilitation Effectiveness On Coronary Artery Diseases Patient's Outcomes

  2020cites this paper
• Vaping Instead of Cigarette Smoking: A Panacea or Just Another form of Cardiovascular Risk?

  2020cites this paper
• Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects

  2019cites this paper